The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Milner, J. D.
Right arrow Articles by Hafler, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Milner, J. D.
Right arrow Articles by Hafler, D. A.
The Journal of Immunology, 1999, 163: 2522-2529.
Copyright © 1999 by The American Association of Immunologists

Differential Responses of Invariant V{alpha}24J{alpha}Q T Cells and MHC Class II-Restricted CD4+ T Cells to Dexamethasone1

Joshua D. Milner2,3,*, Sally C. Kent3,*, Timothy A. Ashley*, S. Brian Wilson{dagger}, Jack L. Strominger{dagger} and David A. Hafler4,*

* Center for Neurologic Diseases, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115; and {dagger} Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02138, and Cancer Immunology and AIDS, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA 02115

NK T cells are a T cell subset in the human that express an invariant {alpha}-chain (V{alpha}24invt T cells). Because of the well-described immunomodulation by glucocorticoids on activation-induced cell death (AICD), the effects of dexamethasone and anti-CD3 stimulation on V{alpha}24invt T cell clones and CD4+ T cell clones were investigated. Dexamethasone significantly enhanced anti-CD3-mediated proliferation of V{alpha}24invt T cells, whereas CD4+ T cells were inhibited. Addition of neutralizing IL-2 Ab partially abrogated dexamethasone-induced potentiation of V{alpha}24invt T cell proliferation, indicating a role for autocrine IL-2 production in corticosteroid-mediated proliferative augmentation. Dexamethasone treatment of anti-CD3-stimulated V{alpha}24invt T cells did not synergize with anti-Fas blockade in enhancing proliferation or preventing AICD. The V{alpha}24invt T cell response to dexamethasone was dependent on the TCR signal strength. In the presence of dexamethasone, lower doses of anti-CD3 inhibited proliferation of V{alpha}24invt T cells and CD4+ T cells; at higher doses of anti-CD3, which caused inhibition of CD4+ T cells, the V{alpha}24invt T cell clones proliferated and were rescued from AICD. These results demonstrate significant differences in TCR signal strength required between V{alpha}24invt T cells and CD4+ cells, and suggest important immunomodulatory consequences for endogenous and exogenous corticosteroids in immune responses.




This article has been cited by other articles:


Home page
Int ImmunolHome page
M. D. Smithgall, M. R. Comeau, B.-R. Park Yoon, D. Kaufman, R. Armitage, and D. E. Smith
IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK Cells
Int. Immunol., August 1, 2008; 20(8): 1019 - 1030.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. H. Chang, N. Liu, V. Klimek, H. Hassoun, A. Mazumder, S. D. Nimer, S. Jagannath, and M. V. Dhodapkar
Enhancement of ligand-dependent activation of human natural killer T cells by lenalidomide: therapeutic implications
Blood, July 15, 2006; 108(2): 618 - 621.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. C. Kent, Y. Chen, S. M. Clemmings, V. Viglietta, N. S. Kenyon, C. Ricordi, B. Hering, and D. A. Hafler
Loss of IL-4 Secretion from Human Type 1a Diabetic Pancreatic Draining Lymph Node NKT Cells
J. Immunol., October 1, 2005; 175(7): 4458 - 4464.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
C. Baecher-Allan and D. A. Hafler
Suppressor T Cells in Human Diseases
J. Exp. Med., August 2, 2004; 200(3): 273 - 276.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. J. J. van der Vliet, J. W. Molling, N. Nishi, A. J. Masterson, W. Kolgen, S. A. Porcelli, A. J. M. van den Eertwegh, B. M. E. von Blomberg, H. M. Pinedo, G. Giaccone, et al.
Polarization of V{alpha}24+ V{beta}11+ Natural Killer T Cells of Healthy Volunteers and Cancer Patients Using {alpha}-Galactosylceramide-loaded and Environmentally Instructed Dendritic Cells
Cancer Res., July 15, 2003; 63(14): 4101 - 4106.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.